Research Catalog

Details

Description

1. iv, 121 pages : illustrations; 24 cm.

Series statement

1. S. hrg. ; 112-934
2. United States. Congress. Senate. S. hrg. ; 112-934.

Subject

1. Drugs > Dosage forms > United States
2. Drug factories > Inspection > United States
3. Drug adulteration > United States > Prevention
4. Meningitis > United States > Prevention

Genre/Form

1. Legislative hearings.

Call number

1. GPO Microfiche Y 4.L 11/4:S.HRG.112-934

Note

1. Shipping list no.: 2015-0234-M.

Bibliography (note)

1. Includes bibliographical references.

Reproduction (note)

1. Microfiche.

Author

1. United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.

Title

1. Pharmacy compounding: implications of the 2012 meningitis outbreak : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session on examining pharmacy compounding, focusing on implications of the 2012 meningitis outbreak, November 15, 2012.

Publisher

1. Washington : U.S. Government Publishing Office, 2015.

Distributor

1. Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office

Type of content

1. text

Type of medium

1. microform

Type of carrier

1. microfiche

Series

1. S. hrg. ; 112-934
2. United States. Congress. Senate. S. hrg. ; 112-934.

Bibliography

1. Includes bibliographical references.

Reproduction

1. Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2015] 2 microfiches : negative.

Other form:

1. Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Pharmacy compounding: implications of the 2012 meningitis outbreak (DLC) 2014496483 (OCoLC)910324881
2. Online version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Pharmacy compounding (OCoLC)908839481

Gpo item no.

1. 1043-B (MF)

Sudoc no.

1. Y 4.L 11/4:S.HRG.112-934